NanoEntek Participates in US Bioprocessing Conference

[Asia Economy Reporter Hyungsoo Park] NanoEntek is participating in a leading U.S. bio processing conference to secure new clients.

On the 12th, NanoEntek announced that it will participate in the Bioprocessing Summit Boston 2022, held from the 15th to the 18th.

NanoEntek will introduce its automatic cell counters, the ADAM series. They will showcase the cGMP facility automatic cell counter ‘ADAM-CellT’ and the automatic multi-cell counter ‘EVE-HT’. The company is actively targeting the U.S. bioprocessing and cell therapy markets.

Now in its 14th year, the Bioprocessing Summit Conference is attended by more than 1,200 top researchers and experts in bio process R&D and Quality Control. It is an annual event where the latest research results and theories are presented and discussed.

Major competitors such as Beckmancoulter and ChemoMetec will also participate. NanoEntek will introduce automatic counting products applying its microparticle counting technology and promote partnering meetings.

Microparticle counting technology is a core technology that enhances the representativeness of samples needed to accurately determine cell counts. It has the advantage of securing stable representativeness with fewer samples compared to competing products. While competing equipment requires 170 to 300 ㎕ (microliters) of sample, NanoEntek can achieve this with only 50 ㎕.

A company official said, "This is a great opportunity to raise product awareness by introducing our cell counters for the first time and to secure new clients," adding, "We plan to actively promote to major overseas buyers."

This content was produced with the assistance of AI translation services.